Spectrum of Vascular Thrombosis in Critically Ill COVID-19 Patients: From Bench to the Bedside
Sonali Vadi1, Ashwini Pednekar1, Abhijit Raut2
1Department of Intensive Care Medicine, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, Maharashtra, India.
Abstract:
Proinflammatory cytokines and procoagulant factors released by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lead to thrombosis and ischemia. Pathogenesis and clinical significance of hypercoagulability and an ensuing gamut of vascular complications are explained here.
How To Cite This Article:
Vadi S, Pednekar A, Raut A. Spectrum of Vascular Thrombosis in Critically Ill COVID-19 Patients: From Bench to the Bedside. Indian J Crit Care Med 2022;26(12):1237-1243.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis I: Introduction
Pulmonary Embolism I: Introduction

